Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis.
BACKGROUND
Barriers experienced by patients influence the uptake of colorectal cancer (CRC) screening. Prior research has quantified how often patients encounter these challenges but has generally not revealed their complex perspective and experience with barriers.


OBJECTIVE
This mixed-methods study was conducted to understand current perspectives on CRC screening.


METHODS
A two-part, mixed-methods study was conducted of primary care patients recruited from Virginia Ambulatory Care Outcomes Research Network practices. First, in June-July 2005 a survey was mailed to 660 patients aged 50-75 years posing an open-ended question about "the most important barrier" to CRC screening. Second, beginning in October 2005, seven gender- and largely race-specific focus groups involving 40 patients aged 45-75 years were conducted. Beginning in October 2005, survey verbatim responses were coded and quantitatively analyzed and focus group transcripts were qualitatively analyzed.


RESULTS
Responses to the open-ended survey question, answered by 74% of respondents, identified fear and the bowel preparation as the most important barriers to screening. Only 1.6% of responses cited the absence of physician advice. Focus group participants cited similar issues and other previously reported barriers, but their remarks exposed the intricacies of complex barriers, such as fear, lack of information, time, the role of physicians, and access to care. Participants also cited barriers that have little documentation in the literature, such as low self-worth, "para-sexual" sensitivities, fatalism, negative past experiences with testing, and skepticism about the financial motivation behind screening recommendations.


CONCLUSIONS
Mixed-methods analysis helps to disaggregate the complex nuances that influence patient behavior. In the present study, patients explained the web of influences on knowledge, motivation, and ability to undergo CRC screening, which clinicians and policymakers should consider in designing interventions to increase the level of screening.
Jones
Resa M
RM
Department of Epidemiology and Community Health, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. rmjones2@vcu.edu
Devers
Kelly J
KJ
Kuzel
Anton J
AJ
Woolf
Steven H
SH
D000368:Aged; D001364:Awareness; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D005260:Female; D017144:Focus Groups; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D009042:Motivation; D010342:Patient Acceptance of Health Care
Gastroenterology. 2008 May;134(5):1570-95
18384785
Prev Med. 2003 Jan;36(1):85-91
12473428
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30
18628413
Cancer Causes Control. 2008 Mar;19(2):195-206
18038186
J Cancer Educ. 2008 Jan-Mar;23(1):32-6
18444044
J Gen Intern Med. 2005 Nov;20(11):977-83
16307620
N Engl J Med. 2000 Nov 30;343(22):1603-7
11096167
Prev Chronic Dis. 2006 Oct;3(4):A123
16978498
N Engl J Med. 2000 Nov 30;343(22):1641-3
11096175
Health Serv Res. 1999 Dec;34(5 Pt 2):1153-88
10591278
Am J Prev Med. 2002 Jul;23(1):28-35
12093420
Am J Prev Med. 2010 May;38(5):499-507
20347555
Gut. 2002 Jan;50(1):29-32
11772963
Cancer Pract. 2000 Jan-Feb;8(1):32-7
10732537
Lancet. 1996 Nov 30;348(9040):1467-71
8942774
Cancer. 2004 May 15;100(10):2093-103
15139050
Cancer Detect Prev. 2006;30(1):67-74
16458449
Prev Med. 2004 Mar;38(3):258-68
14766107
Health Expect. 2007 Jun;10(2):148-60
17524008
J Community Health. 2000 Jun;25(3):263-78
10868818
Ann Fam Med. 2004 Jan-Feb;2(1):4-6
15053276
Ethn Dis. 2006 Spring;16(2):421-7
17682244
J Gen Intern Med. 2008 Jun;23(6):834-40
18350339
Ann Intern Med. 2008 Nov 4;149(9):627-37
18838716
BMC Public Health. 2004 Dec 15;4:62
15601463
BMC Fam Pract. 2008 Feb 27;9:15
18304342
BMJ. 2008 Aug 07;337:a567
18687728
J Natl Cancer Inst. 1999 Mar 3;91(5):434-7
10070942
MMWR Morb Mortal Wkly Rep. 2008 Mar 14;57(10):253-8
18340331
Ethn Dis. 2006 Winter;16(1):255-61
16599380
Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):529-34
12050093
Ann Fam Med. 2004 Jan-Feb;2(1):7-12
15053277
J Natl Med Assoc. 2005 Feb;97(2):162-70
15712779
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Med Care. 2005 Sep;43(9):939-44
16116360
J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22
9326910
Prev Med. 2000 Sep;31(3):261-70
10964640
Wis Med J. 1997 Aug;96(8):32-7
9283263